These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Vollenweider FX; Kometer M Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121 [TBL] [Abstract][Full Text] [Related]
7. The potential of psychedelics for the treatment of Alzheimer's disease and related dementias. Winkelman MJ; Szabo A; Frecska E Eur Neuropsychopharmacol; 2023 Nov; 76():3-16. PubMed ID: 37451163 [TBL] [Abstract][Full Text] [Related]
8. Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Vollenweider FX; Preller KH Nat Rev Neurosci; 2020 Nov; 21(11):611-624. PubMed ID: 32929261 [TBL] [Abstract][Full Text] [Related]
9. The Effects of Hallucinogens on Gene Expression. Martin DA; Nichols CD Curr Top Behav Neurosci; 2018; 36():137-158. PubMed ID: 28677095 [TBL] [Abstract][Full Text] [Related]
10. Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities. Yaden DB; Johnson MW; Griffiths RR; Doss MK; Garcia-Romeu A; Nayak S; Gukasyan N; Mathur BN; Barrett FS Int J Neuropsychopharmacol; 2021 Aug; 24(8):615-623. PubMed ID: 33987652 [TBL] [Abstract][Full Text] [Related]
12. An introduction to psychedelic neuroscience. Calvey T; Howells FM Prog Brain Res; 2018; 242():1-23. PubMed ID: 30471677 [TBL] [Abstract][Full Text] [Related]
13. What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying. Mackenzie R Curr Drug Abuse Rev; 2014; 7(3):136-45. PubMed ID: 25563449 [TBL] [Abstract][Full Text] [Related]
14. Mini-review: The neurobiology of treating substance use disorders with classical psychedelics. Urban MM; Stingl MR; Meinhardt MW Front Neurosci; 2023; 17():1156319. PubMed ID: 37139521 [TBL] [Abstract][Full Text] [Related]
15. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders. Mertens LJ; Preller KH Pharmacopsychiatry; 2021 Jul; 54(4):176-190. PubMed ID: 33472250 [TBL] [Abstract][Full Text] [Related]
16. Beating pain with psychedelics: Matter over mind? Elman I; Pustilnik A; Borsook D Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987 [TBL] [Abstract][Full Text] [Related]
17. The Effects of Psychedelics on Neuronal Physiology. Hatzipantelis CJ; Olson DE Annu Rev Physiol; 2024 Feb; 86():27-47. PubMed ID: 37931171 [TBL] [Abstract][Full Text] [Related]
18. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders. Kozlowska U; Nichols C; Wiatr K; Figiel M J Neurochem; 2022 Jul; 162(1):89-108. PubMed ID: 34519052 [TBL] [Abstract][Full Text] [Related]
19. Psychedelic drugs for psychiatric disorders. da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696 [TBL] [Abstract][Full Text] [Related]
20. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Dourron HM; Strauss C; Hendricks PS Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]